These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 17962044

  • 21. Feasibility of [18F]-2-Fluoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivo.
    Bucerius J, Manka C, Schmaljohann J, Mani V, Gündisch D, Rudd JH, Bippus R, Mottaghy FM, Wüllner U, Fayad ZA, Biersack HJ.
    JACC Cardiovasc Imaging; 2012 May; 5(5):528-36. PubMed ID: 22595161
    [Abstract] [Full Text] [Related]

  • 22. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
    Doll F, Dolci L, Valette H, Hinnen F, Vaufrey F, Guenther I, Fuseau C, Coulon C, Bottlaender M, Crouzel C.
    J Med Chem; 1999 Jun 17; 42(12):2251-9. PubMed ID: 10377231
    [Abstract] [Full Text] [Related]

  • 23. Imaging of central nAChReceptors with 2-[18F]F-A85380: optimized synthesis and in vitro evaluation in Alzheimer's disease.
    Schmaljohann J, Minnerop M, Karwath P, Gündisch D, Falkai P, Guhlke S, Wüllner U.
    Appl Radiat Isot; 2004 Dec 17; 61(6):1235-40. PubMed ID: 15388115
    [Abstract] [Full Text] [Related]

  • 24. Positron emission tomography experience with 2-[¹⁸F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[¹⁸F]FA) in the living human brain of smokers with paranoid schizophrenia.
    Brašić JR, Cascella N, Kumar A, Zhou Y, Hilton J, Raymont V, Crabb A, Guevara MR, Horti AG, Wong DF.
    Synapse; 2012 Apr 17; 66(4):352-68. PubMed ID: 22169936
    [Abstract] [Full Text] [Related]

  • 25. Equilibrium modeling of 5-HT(2A) receptors with [18F]deuteroaltanserin and PET: feasibility of a constant infusion paradigm.
    van Dyck CH, Soares JC, Tan PZ, Staley JK, Baldwin RM, Amici LA, Fu X, Garg PK, Seibyl JP, Charney DS, Innis RB.
    Nucl Med Biol; 2000 Nov 17; 27(8):715-22. PubMed ID: 11150702
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of the sensitivity of the novel α4β2* nicotinic acetylcholine receptor PET radioligand 18F-(-)-NCFHEB to increases in synaptic acetylcholine levels in rhesus monkeys.
    Gallezot JD, Esterlis I, Bois F, Zheng MQ, Lin SF, Kloczynski T, Krystal JH, Huang Y, Sabri O, Carson RE, Cosgrove KP.
    Synapse; 2014 Nov 17; 68(11):556-64. PubMed ID: 25043426
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study.
    Picard F, Bruel D, Servent D, Saba W, Fruchart-Gaillard C, Schöllhorn-Peyronneau MA, Roumenov D, Brodtkorb E, Zuberi S, Gambardella A, Steinborn B, Hufnagel A, Valette H, Bottlaender M.
    Brain; 2006 Aug 17; 129(Pt 8):2047-60. PubMed ID: 16815873
    [Abstract] [Full Text] [Related]

  • 29. Feasibility of 2-deoxy-2-[18F]fluoro-D-glucose- A85380-PET for imaging of human cardiac nicotinic acetylcholine receptors in vivo.
    Bucerius J, Joe AY, Schmaljohann J, Gündisch D, Minnerop M, Biersack HJ, Wüllner U, Reinhardt MJ.
    Clin Res Cardiol; 2006 Feb 17; 95(2):105-9. PubMed ID: 16598519
    [Abstract] [Full Text] [Related]

  • 30. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
    Sabri O, Becker GA, Meyer PM, Hesse S, Wilke S, Graef S, Patt M, Luthardt J, Wagenknecht G, Hoepping A, Smits R, Franke A, Sattler B, Habermann B, Neuhaus P, Fischer S, Tiepolt S, Deuther-Conrad W, Barthel H, Schönknecht P, Brust P.
    Neuroimage; 2015 Sep 17; 118():199-208. PubMed ID: 26037057
    [Abstract] [Full Text] [Related]

  • 31. A simple and fast method for the preparation of n.c.a. 2-[18F]F-A85380 for human use.
    Schmaljohann J, Gündisch D, Minnerop M, Joe A, Bucerius J, Dittmar C, Jessen F, Guhlke S, Wüllner U.
    Appl Radiat Isot; 2005 Oct 17; 63(4):433-5. PubMed ID: 16024252
    [Abstract] [Full Text] [Related]

  • 32. Binding properties of the cerebral alpha4beta2 nicotinic acetylcholine receptor ligand 2-[18F]fluoro-A-85380 to plasma proteins.
    Sorger D, Becker GA, Hauber K, Schildan A, Patt M, Birkenmeier G, Otto A, Meyer P, Kluge M, Schliebs R, Sabri O.
    Nucl Med Biol; 2006 Oct 17; 33(7):899-906. PubMed ID: 17045170
    [Abstract] [Full Text] [Related]

  • 33. In vitro evaluation of nicotinic acetylcholine receptors with 2-[18F]F-A85380 in Parkinson's disease.
    Schmaljohann J, Gündisch D, Minnerop M, Bucerius J, Joe A, Reinhardt M, Guhlke S, Biersack HJ, Wüllner U.
    Nucl Med Biol; 2006 Apr 17; 33(3):305-9. PubMed ID: 16631078
    [Abstract] [Full Text] [Related]

  • 34. 2-[18F]F-A-85380: a PET radioligand for alpha4beta2 nicotinic acetylcholine receptors.
    Chefer SI, Horti AG, Koren AO, Gündisch D, Links JM, Kurian V, Dannals RF, Mukhin AG, London ED.
    Neuroreport; 1999 Sep 09; 10(13):2715-21. PubMed ID: 10511429
    [Abstract] [Full Text] [Related]

  • 35. Assessment of α7 nicotinic acetylcholine receptor availability in juvenile pig brain with [¹⁸F]NS10743.
    Deuther-Conrad W, Fischer S, Hiller A, Becker G, Cumming P, Xiong G, Funke U, Sabri O, Peters D, Brust P.
    Eur J Nucl Med Mol Imaging; 2011 Aug 09; 38(8):1541-9. PubMed ID: 21484373
    [Abstract] [Full Text] [Related]

  • 36. Measurement of the alpha4beta2* nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study.
    Sorger D, Becker GA, Patt M, Schildan A, Grossmann U, Schliebs R, Seese A, Kendziorra K, Kluge M, Brust P, Mukhin AG, Sabri O.
    Nucl Med Biol; 2007 Apr 09; 34(3):331-42. PubMed ID: 17383583
    [Abstract] [Full Text] [Related]

  • 37. Simple and rapid quantification of serotonin transporter binding using [11C]DASB bolus plus constant infusion.
    Gryglewski G, Rischka L, Philippe C, Hahn A, James GM, Klebermass E, Hienert M, Silberbauer L, Vanicek T, Kautzky A, Berroterán-Infante N, Nics L, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Kasper S, Lanzenberger R.
    Neuroimage; 2017 Apr 01; 149():23-32. PubMed ID: 28119137
    [Abstract] [Full Text] [Related]

  • 38. PET imaging of high-affinity α4β2 nicotinic acetylcholine receptors in humans with 18F-AZAN, a radioligand with optimal brain kinetics.
    Wong DF, Kuwabara H, Kim J, Brasic JR, Chamroonrat W, Gao Y, Valentine H, Willis W, Mathur A, McCaul ME, Wand G, Gean EG, Dannals RF, Horti AG.
    J Nucl Med; 2013 Aug 01; 54(8):1308-14. PubMed ID: 23801676
    [Abstract] [Full Text] [Related]

  • 39. 18F-ZW-104: a new radioligand for imaging neuronal nicotinic acetylcholine receptors--in vitro binding properties and PET studies in baboons.
    Valette H, Xiao Y, Peyronneau MA, Damont A, Kozikowski AP, Wei ZL, Kassiou M, Kellar KJ, Dollé F, Bottlaender M.
    J Nucl Med; 2009 Aug 01; 50(8):1349-55. PubMed ID: 19652217
    [Abstract] [Full Text] [Related]

  • 40. 123I-5-IA-85380 SPECT imaging of nicotinic receptors in Alzheimer disease and mild cognitive impairment.
    Mitsis EM, Reech KM, Bois F, Tamagnan GD, Macavoy MG, Seibyl JP, Staley JK, van Dyck CH.
    J Nucl Med; 2009 Sep 01; 50(9):1455-63. PubMed ID: 19690024
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.